A phase 2 trial of PHV01

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 27 Mar 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

27 Mar 2024 New trial record
21 Mar 2024 According to a Public Health Vaccines media release, PHV01 has been funded by the BARDA, part of the HHS Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services under contract number HHSO100201900022C. If PHV development efforts continue successfully, BARDA has the option to provide up to $72 million in funding, enabling the completion of a Phase 2 clinical trial and additional activities on the regulatory path to approval.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com